Why the study?
Does coronary endothelial dysfunction predict long-term adverse outcomes in patients with chest pain and non-obstructive coronary artery disease?
Does coronary endothelial dysfunction predict long-term adverse outcomes in patients with chest pain and non-obstructive coronary artery disease?
In patients with chest pain and non-obstructive coronary artery disease, adverse cardiovascular events are frequent and related to both endothelial dysfunction and traditional risk factors.
High event rates occur in non-obstructive CAD regardless of endothelial dysfunction; leaves open its independent prognostic value beyond traditional risks.
Coronary endothelial dysfunction is known to be related with adverse cardiovascular outcome. We obtained a long-term follow-up of patients without significant coronary atherosclerosis, complaining of chest pain, in whom intra-coronary acetylene testing was performed in order to assess endothelial function. The study included 41 patient (35 with endothelial dysfunction, 6 with preserved endothelial function). Events considered as adverse outcome were cardiovascular death, acute myocardium-dial infarction, unstable angina pectoris, percutaneous coronary intervention, coronary-aortic by-pass grafting, ischemic stroke and peripheral artery re-vascularization. A high cardiovascular event rate was observed in patients with and without endothelial dysfunction, 34,3% and 50% respectively. Adverse outcome was related not only to endothelial dysfunction but also to traditional cardiovascular risk factors. Thus, evaluation of endothelial function or its determinants seems to be helpful in identifying a subgroup of patients at high risk.
No takes yet. Share an insight, caveat, or question.
Jarašūnienė et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: